Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramChief Legal OfficerCIK 0001817199
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $245K 9,527 sh | Nov 4, 2026 traded Nov 2, 2026 | |
Ring ChristineChief Legal Officer |
| NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan |
| SELL |
| $158K 6,113 sh |
| Nov 4, 2026 traded Nov 3, 2026 |
| 3 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $50K 5,786 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 5,786 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $29K 1,075 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 10 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,859 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 6 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 10 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,859 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 35 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale | SELL | $104K 3,957 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 14 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 10 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 10 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,573 sh | Nov 2, 2026 traded Oct 30, 2026 |
| 0 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 15.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 21 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $581K 28.9K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 7 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $136K 15.6K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 7 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $97K 13.3K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 0 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 13.3K sh | Jun 25, 2026 traded Jun 25, 2026 |
| 15 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $90K 5,394 sh | May 1, 2026 traded May 1, 2026 |
| 6 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,858 sh | Apr 30, 2026 traded Apr 30, 2026 |
| 6 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,858 sh | Apr 30, 2026 traded Apr 30, 2026 |
| 31 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale | SELL | $53K 3,214 sh | Apr 30, 2026 traded Apr 30, 2026 |
| 2 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,000 sh | Apr 30, 2026 traded Apr 30, 2026 |
| 6 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Apr 30, 2026 traded Apr 30, 2026 |
| 6 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,000 sh | Apr 30, 2026 traded Apr 30, 2026 |
| 10 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Apr 30, 2026 traded Apr 30, 2026 |
| 19 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $238K 14.3K sh | Feb 9, 2026 traded Feb 9, 2026 |
| 5 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,859 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 13 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 27 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale | SELL | $1,529 88 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 5 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,000 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 9 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,859 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 34 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale | SELL | $72K 4,333 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 5 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 2,000 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 5 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 1,925 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 5 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 1,925 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 9 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise | M | — 3,750 sh | Jan 30, 2026 traded Jan 30, 2026 |
| 0 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $6,994 3,760 sh | Jan 20, 2026 traded Jan 20, 2026 |
| 18 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $69K 3,760 sh | Jan 20, 2026 traded Jan 20, 2026 |
| 7 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 3,760 sh | Jan 20, 2026 traded Jan 20, 2026 |
| 0 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $6,994 3,760 sh | Dec 18, 2025 traded Dec 18, 2025 |
| 8 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $64K 3,560 sh | Dec 18, 2025 traded Dec 18, 2025 |
| 3 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 3,760 sh | Dec 18, 2025 traded Dec 18, 2025 |
| 1 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $3,711 200 sh | Dec 18, 2025 traded Dec 18, 2025 |
| 0 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 37.6K sh | Nov 24, 2025 traded Nov 24, 2025 |
| 14 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $70K 37.6K sh | Nov 24, 2025 traded Nov 24, 2025 |
| 19 | Ring ChristineChief Legal Officer | NRIXNurix Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $642K 37.6K sh | Nov 24, 2025 traded Nov 24, 2025 |